Export

EN
FR
Anti-d immunoglobulin
Essential medicine status
Section:
11. Blood products of human origin and plasma substitutes 11.2. Plasma-derived medicines 11.2.1. Human immunoglobulins
ATC codes: J06BB01
Indication
Rh incompatibility reaction ICD11 code: NE80.2
Medicine type
Biological agent
List type
Core
Additional notes
All human plasma-derived medicines should comply with WHO requirements.
Formulations
Parenteral > General injections > IV: 250 µg in single-dose vial
Parenteral > General injections > IM: 250 µg in single-dose vial
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1982 (TRS 685)
Changed in 1989 (TRS 796)
Changed in 2015 (TRS 994)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Tags
Wikipedia
Anti-d immunoglobulin
DrugBank
Anti-d immunoglobulin (Human Rho(D) immune globulin)
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended that immunoglobulins of human origin currently listed in Section 19.2 Sera and immunoglobulins, should be transferred to Section 11.2.1 Human immunoglobulins.